• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchZynerba Pharmaceuticals
    Picture of Zynerba Pharmaceuticals logo

    ZYNE — Zynerba Pharmaceuticals News Story

    $1.300.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall Cap
    • Market Cap
      $70.12m
    • Enterprise Value
      $34.15m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ZYNE Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ZYNE Dividends
    All News

    NASDAQ RESUMED AT 03:15 PM

    Picture of Zynerba Pharmaceuticals logoZynerba Pharmaceuticals
    15/10/2020 20:15
    NASDAQ RESUMED  ZYNE.O  AT 03:15 PM
    

    Recent news on Zynerba Pharmaceuticals

    See all news
    • Brief: Harmony Biosciences Completes Acquisition Of Zynerba Pharmaceuticals

      11/10/2023 13:16
    • Brief: Harmony Biosciences Announces Extension Of Tender Offer To Acquire Zynerba Pharmaceuticals, Inc.

      27/09/2023 13:06
    • Brief: Zynerba Pharmaceuticals Presents Positive Data From Phase 2 Inspire Trial

      14/09/2023 22:03
    • U.S. RESEARCH ROUNDUP-Easterly Government Properties, Visa, Zynerba Pharmaceuticals

      16/08/2023 08:15
    • Zynerba Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

      15/08/2023 02:12

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.